Results

Total Results: 2,078 records

Showing results for "drugs".

381. S1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
     October 01, 2007 - health of many Americans as well as the effectiveness of nearly all other health care services in which pharmaceuticals … As the federal government becomes a major payer of prescription drugs while also providing insurance

382. Treatments for Seasonal Allergic Rhinitis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/allergy-seasonal/research-protocol
     March 08, 2012 - Six classes of drugs and nasal saline are used to treat SAR. … Several drugs have more than one route of administration (e.g., intranasal and oral), as described below … These drugs are commonly administered prophylactically, before an allergic reaction is triggered, during … for clinical trials, data demonstrating efficacy and maternal and fetal safety are lacking for most drugs … Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/

383. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Curr Opin Investig Drugs. 2001 Apr;2(4):505-9. PMID: 11566007 30. Tappenden K, Edelman J. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec [accessed 2013 Jun 5]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Oct 16 [accessed 2012 Oct 16]. [3 p].

384. Disposition of Comments Report for Acute Migraine Treatment in Emergency Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
     November 27, 2012 - We understand that many drugs have different mechanisms of action (e.g., an antiemetic can have analgesic … Promethazine (Phenergan) was included in Table 1 under the “other agents” portion as one of the drugs … Peer Reviewer #2 Executive summary In the Executive Summary, drugs are loosely discussed in terms … of neuroleptics, metoclopramide, and antihistamines (without specific drugs listed), while in the … We collectively referred to these drugs as “orphan agents”.

385. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … ..................................................... 5 1 Disease-Modifying Antirheumatic Drugs … Introduction Comparative Effectiveness Review (CER) #28, Disease-Modifying Antirheumatic Drugs … examples of how advances in understanding the biology of inflammation have led to development of drugs … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis (JIA)

386. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … ..................................................... 5 1 Disease-Modifying Antirheumatic Drugs … Introduction Comparative Effectiveness Review (CER) #28, Disease-Modifying Antirheumatic Drugs … examples of how advances in understanding the biology of inflammation have led to development of drugs … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis (JIA)

387. Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Nosocomial Pneumonia | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/pneumonia-antibiotic-treatment/research-protocol
     July 19, 2013 - For drugs with a narrow therapeutic index, such as vancomycin and the aminoglycosides, the risk of toxicities … also reduce nephrotoxicity in patients who are receiving aggressive dosing, concurrent nephrotoxic drugs … discussion, a new KQ was added to examine the effect of using prolonged or continuous infusions of drugs … creatinine clearance, time above MIC, and ratio of AUC to MIC (see Table 1 below for drug classes and drugs … Relationship OR MIC OR AUC OR Microbial Sensitivity OR Time Kill Curve) Antibiotics (Terms for drugs

388. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - have also emerged since 2010 which may change the balance of benefit and risk attributable to these drugs … In this era of intensive direct-to-consumer marketing of new drugs, clinicians need a trustworthy source … Health and Human Services; 2008 [cited 2014 July 13]; Available from: http://www.fda.gov/downloads/Drugs … Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs … http:www.effectivehealthcare.ahrq.gov http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation

389. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Drugs Today. 2010;46(1):49-67. 3. Sorbera LA, Dulsat C, Rosa E. … East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2012 May. 22 p. … Drugs Future. 2010;35(2):93-7. … Also available: http://blue.regence.com/trgmedpol/drugs/dru256. pdf. 46.

390. Disposition of Comments Report for Stroke Prevention in Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
     August 23, 2013 - Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … Acknowledged Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … No known reversibility agents for the new drugs. Thank you for this comment.

391. Methods Guide Atkins (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
     January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … and discrete populations, used different drugs, different dosages, and different cointerventions. … differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin drugs … Drugs 2007;67(14):1969-1979. 20. Walker, CF, Kordas K, Stoltzfus, RJ, et al. … Drug class review of Alzheimer’s drugs. Final report. 2006.

392. Methods-Guidance-Applicability Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
     January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … and discrete populations, used different drugs, different dosages, and different cointerventions. … differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin drugs … Drugs 2007;67(14):1969-1979. 20. Walker, CF, Kordas K, Stoltzfus, RJ, et al. … Drug class review of Alzheimer’s drugs. Final report. 2006.

393. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
     February 16, 2011 - scientific evidence (level A) for using combined oral contraceptives and nonsteroidal anti-inflammatory drugs … Medical therapies • Analgesics o Non-narcotic agents including nonsteroidal anti-inflammatory drugs … Broad searches for grey literature and regulatory information on such commonly used drugs would likely … We consulted the TEP to determine which studies of drugs or devices would be likely to provide relevant … Our research team also thought it important to search for other drugs (e.g., aromatase inhibitors) that

394. Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
     November 01, 2016 - Pain Type of Medicine About the medicine: Researchers found: NSAIDs (nonsteroidal anti- inflammatory drugs … Type of Medicine About the medicine: Researchers found: NSAIDs (nonsteroidal anti- inflammatory drugs … Possible Side Effects NSAIDs (nonsteroidal anti-inflammatory drugs) – Celecoxib (Celebrex®), diclofenac

395. Medication Therapy Management | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/medication-therapy-management/research-protocol
     July 24, 2013 - programs target Medicare Part D enrollees, who have multiple chronic diseases, are taking multiple Part D drugs … , and are likely to incur annual costs for covered Part D drugs that exceed a predetermined level (“annual … A plan may require no more than eight Part D drugs, although they may set at the maximum at any number … personal medication report, which is a written list of the patient’s prescription and nonprescription drugs … Drugs. 2009;69(4):393-406. PMID: 19323584. Lewin Group.

396. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
     March 01, 2009 - the Agency for Healthcare Research and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals … , Medicure, Medtronic Vascular, Bristol-Myers Squibb, and Novartis Pharmaceuticals. … Institute, the Agency for Healthcare Research and Quality, Proctor & Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals

397. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
     January 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p]. … Get drugs straight to the eye. [internet].

398. Comparative Effectiveness and Safety of New Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
     July 01, 2010 - Exenatide, manufactured as Byetta by Amylin Pharmaceuticals, Inc. … Additionally, a separate, linkable file is available which includes pharmacy claims for prescription drugs … In Table 3, we provide details about the other drugs for DM used by these patients. … Experts weigh in on promotion, prescription of off-label drugs. JAMA 2007;297:683-684. 15.

399. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/could-the-cost-of-additional-staffing-and-techniques-utilizing-lesser-restrictive-interventions-with-pyschiatric-patients-provide-an-overall-reduction-of-spending-for-institutions-versus-total-spending-with-current-use-of-sec
     August 14, 2012 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to

400. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-fecal-incontinence-especially-women-who-sustained-injury-from-forceps-delivery-that-now-manifests-as-fecal-incontinence-in-advanced-age-what-permanent-reliable-and-effective-treatments-are-available-to-retur
     July 27, 2012 - no If yes, explain the specific technologies, devices, drugs, or interventions you would like to